Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 34, 2021 - Issue 1
51
Views
3
CrossRef citations to date
0
Altmetric
Case Studies

Refractory dermatomyositis–systemic lupus erythematosus overlap syndrome and response to tofacitinib

, BAORCID Icon & , MDORCID Icon
Pages 116-117 | Received 07 Jul 2020, Accepted 04 Sep 2020, Published online: 28 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kareem G Elhage, Raymond Zhao & Mio Nakamura. (2022) Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature. Clinical, Cosmetic and Investigational Dermatology 15, pages 1815-1831.
Read now

Articles from other publishers (2)

Carole Bitar, Thien Ninh, Katherine Brag, Soraya Foutouhi, Stella Radosta, Jade Meyers, Melody Baddoo, Delong Liu, Brittany Stumpf, Paul W. Harms, Nakhle S. Saba & Erin Boh. (2022) Apremilast in Recalcitrant Cutaneous Dermatomyositis. JAMA Dermatology 158:12, pages 1357.
Crossref
Przemysław Kotyla, Olga Gumkowska-Sroka, Bartosz Wnuk & Kacper Kotyla. (2022) Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus. Pharmaceuticals 15:8, pages 936.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.